Boardroom Alpha
Boardroom Alpha
IPAR · Current Report (Form 8-K) · Filed August 4, 2026

Interparfums Inc — Current Report (Form 8-K)

Form
8-K
Filed
August 4, 2026
Period
Aug 4, 2026
Ticker
IPAR
Accession
0001753926-26-001319
Boardroom Alpha · Filing insights

Interparfums reports Q2 2026 results, reaffirms 2026 guidance, and outlines investments and fragrance initiatives.

About Interparfums Inc
Market cap
$3.6B
1Y TSR
+11.0%
3Y TSR
−3.0%
Board grade
B+
Sector
Consumer Defensive
CEO
Jean Madar
Last annual meeting: Sep 15, 2026 · View full Interparfums Inc profile →
ipar-20260804.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 Date of Report (Date of Earliest Event Reported): August 4, 2026 

 
Interparfums, Inc.
(Exact name of Registrant as specified in its charter)

 

Delaware

 

0-16469

 

13-3275609

(State or other jurisdiction of
incorporation or organization)

 

Commission
File Number

 

(I.R.S. Employer
Identification No.)

 

551 Fifth Avenue, New York, NY 10176
(Address of Principal Executive Offices)

 

212.983.2640
(Registrant’s Telephone number, including area code)

 

   (Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading Symbol(s)

 

Name of each exchange
on which registered

 

 

 

 

 

 Common Stock, $.001 par value per share

 

IPAR

 

The Nasdaq Stock Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 2.02 Results of Operations and Financial Conditions

 

Certain portions of our press release dated August 4, 2026, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:

 

         The 1st, 2nd (consisting of a table), 4th, 5th, 6th, 9th through 14th full paragraphs relating to results of operations for the second quarter of 2026

         Part of the 3rd paragraph relating to results of operations for the second quarter of 2026

         Part of the 15th paragraph relating advertising & promotional (“A&P”) expenses and net sales

         The 16th through 18th paragraphs relating to operating margins and effective tax rate

         The 19th paragraph relating to balance sheet items

         The 23rd through 24th paragraphs relating to the previously announced conference call scheduled for August 5, 2026

         The consolidated statements of income and consolidated balance sheets

 

Item 7.01 Regulation FD Disclosure

 

Certain portions of our press release dated August 4, 2026, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01. They are as follows:

 

         Portion of the 3rd paragraph relating to anticipating investments in product initiatives and advertising and promotion spend for the balance of the year and beyond

         The 7th paragraph relating to upcoming fragrance launches relating to the second half of 2026 and major fragrance initiatives planned for 2027 and 2028

         The 8th paragraph relating to the Company’s potential opportunities ahead by maintaining operational discipline

         Part of the 15th paragraph relating to the Company’s plans to reinvest the tariff refunds in 2027 to help grow the business

         The 20th and 21st paragraphs relating to reaffirmance of the previously announced 2026 guidance for the Company

         The 27th paragraph relating to forward-looking information

         The balance of such press release not otherwise incorporated by reference in Item 2.02.

 

Item 8.01 Other Events

         The 22nd paragraph relating to Dividends

 

Item 9.01 Financial Statements and Exhibits.

 

99.1

Our press release dated August 4, 2026

 


 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

 

Dated: August 4, 2026

 

 

Interparfums, Inc.

 

 

 

By:

/s/ Michel Atwood

 

 

Michel Atwood,

 

 

Chief Financial Officer

 


 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Interparfums Inc (IPAR)

Reference

Frequently asked questions

When did Interparfums Inc file this 8-K?
Interparfums Inc (IPAR) filed this Current Report (Form 8-K) with the SEC on August 4, 2026. The accession number assigned by EDGAR is 0001753926-26-001319.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Interparfums reports Q2 2026 results, reaffirms 2026 guidance, and outlines investments and fragrance initiatives. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Interparfums Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Interparfums Inc has filed under CIK 822663, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer